At close: December 20 at 4:10:12 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Cash Flows from Used in Operating Activities Direct
-22,975.9350
-22,975.9350
-23,201.7980
-9,915.6540
Investing Cash Flow
--
--
-1,530.6810
-28,369.8190
Financing Cash Flow
29,876.9450
29,876.9450
9,217.7910
65,110.1140
End Cash Position
18,575.0400
18,575.0400
11,699.0660
26,979.1050
Capital Expenditure
--
--
-1,530.6810
-28,338.6500
Issuance of Capital Stock
29,645.5260
29,645.5260
10,072.5550
70,000.0000
Issuance of Debt
7,369.1900
7,369.1900
--
10.0000
Repayment of Debt
-5,167.0000
-5,167.0000
--
-69.0000
Repurchase of Capital Stock
-1,533.7710
-1,533.7710
-854.7640
-4,830.8860
Free Cash Flow
-22,975.9350
-22,975.9350
-24,732.4790
-38,254.3040
6/30/2022 - 11/24/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%
CHM.AX Chimeric Therapeutics Limited
0.0060
0.00%
TRP.AX Tissue Repair Ltd
0.2600
-3.70%
CHMMF Chimeric Therapeutics Limited
0.0010
0.00%
PPTDF PeptiDream Inc.
17.15
0.00%
T3X.BE Telix Pharmaceuticals Ltd
14.63
-4.07%
SPL.AX Starpharma Holdings Limited
0.0980
-2.00%
RCE.AX Recce Pharmaceuticals Ltd
0.4450
-1.11%
RAC.AX Race Oncology Limited
1.4150
+6.79%
PYC.AX PYC Therapeutics Limited
1.4500
+2.84%